The Limited Times

Now you can see non-English news...

Who is eligible to receive the booster dose in the US?

2021-09-26T03:41:00.925Z

Who is eligible to receive the booster dose in the United States. We tell you who could be the first to receive it.



Pfizer Booster: Will It Get Acceptance in the US?

1:36

(CNN Spanish) -

Booster doses of the Pfizer / BioNTech vaccine against covid-19 can now be officially administered in the United States, but only certain adults are authorized to receive it.

After several days of debate, the US Centers for Disease Control and Prevention (CDC) recommended the application of a booster dose for a larger group of people and also recommended the dose of reinforcement for those in high-risk work settings and institutions.

  • Covid-19 has already killed 675,000 people in the United States.

    Check out other deadly diseases that have plagued the country

With the delta variant dominating in the United States, the CDC believes that the booster dose could help strengthen protection against serious diseases in populations that are at high risk of exposure or complications from Covid-19.

Many of the people now eligible to receive the booster dose were the first to receive the vaccine early in the initial vaccination program.

However, these recommendations only apply to people who previously received both doses of the Pfizer / BioNTech vaccine.

Dr. Huerta: Hydrogen peroxide and iodine do not end with covid-19 1:36

  • CVS Begins Offering Booster Dose of Pfizer Vaccine at Nearly 6,000 Locations

Eligibility to receive the booster dose

The CDC indicates that these people "should" receive the booster dose of the COVID-19 vaccine at least 6 months after they have been fully immunized with two injections:

advertising

  • People 65 and older, and residents in long-term care settings.

  • People ages 50 to 64 with underlying medical conditions.

And "if possible" the following groups of people could receive the COVID-19 vaccine at least 6 months after having been fully immunized with two injections:

  • People ages 18 to 49 with underlying medical conditions, based on their individual benefits and risks.

  • People aged 18 to 64 who are at increased risk of exposure and transmission of COVID-19 due to their work or institutional environment.

    For example: health workers, educational personnel, caregivers of fragile or immunosuppressed people, people in homeless shelters, people in correctional facilities, among others.

Who are more likely to get sick

The CDC states that people with certain medical conditions are more likely to become seriously ill from COVID-19, making them eligible for the COVID-19 booster dose.

The CDC lists the following medical conditions:

  • Cancer

  • Chronic kidney disease

  • Chronic lung diseases, such as: COPD, asthma, interstitial lung disease, cystic fibrosis, and pulmonary hypertension

  • Dementia or other neurological conditions.

  • Type 1 or type 2 diabetes

  • Down's Syndrome

  • Heart conditions, such as: heart failure, coronary artery disease, cardiomyopathy, or hypertension.

  • HIV

  • Immunosuppressed people

  • Liver disease

  • Overweight and obesity

  • Pregnancy

  • Sickle cell disease or thalassemia

  • Tobacco use, current or past

  • Solid Organ or Blood Stem Cell Transplantation

  • Strokes or cerebrovascular diseases, which affect blood flow to the brain

  • Substance use disorders

Is the booster dose key to ending the pandemic?

5:32

What if I received the vaccine from Moderna or Johnson & Johnson?

According to the CDC, people who received the vaccine from Moderna or Johnson & Johnson will likely need a booster shot.

However, at the moment they continue to wait for more data on the efficacy and safety of the booster doses produced by these pharmaceutical companies.

  • Johnson & Johnson's Two-Dose Version Is 94% Effective Against Covid-19, Study Finds

Moderna has asked the U.S. Food and Drug Administration (FDA) to authorize booster injections for its vaccine, but so far the FDA has only considered Pfizer's offer.

Johnson & Johnson released partial data this week indicating that a booster dose greatly increased immunity, but the company has not yet asked the FDA to consider a booster dose.

coronavirusCovid-19Pfizer

Source: cnnespanol

All news articles on 2021-09-26

You may like

News/Politics 2021-09-26T03:55:27.219Z
News/Politics 2021-09-26T03:41:00.925Z
News/Politics 2021-09-16T16:24:00.321Z
News/Politics 2021-09-30T18:31:25.705Z

Trends 24h

News/Politics 2021-10-13T08:27:30.881Z
News/Politics 2021-10-13T07:58:05.911Z
News/Politics 2021-10-12T16:45:07.498Z

Latest

© Communities 2019 - Privacy